Press Releases

 
Press Releases
  Date Title View
May 5, 2017
Primary endpoint showed patients initiated with Relvar Ellipta had twice the odds of achieving an improvement in asthma control compared with patients continuing usual care. LONDON--(BUSINESS WIRE)-- GlaxoSmithKline plc (LSE/NYSE: GSK) and Innoviva Inc (NASDAQ: INVA) today announced...
Apr 27, 2017
Royalties earned in Q1 2017 of $43.7 million, up 60% from Q1 2016 Net income for Q1 2017 of $16.8 million (up 280% from Q1 2016), or $0.16 basic earnings per share, and adjusted earnings per share of $0.19 per share Management will host a conference call and webcast...
Apr 21, 2017
BRISBANE, Calif.--(BUSINESS WIRE)-- Innoviva, Inc. (NASDAQ: INVA) announced today that it will report financial results for the first quarter ended March 31, 2017 after market close on Thursday, April 27, 2017. Following the earnings release, Innoviva management will host a webcast and conference call at ...
Apr 20, 2017
Innoviva Shareholders Support All Seven Innoviva Board Members and Management at Annual Meeting BRISBANE, Calif.--(BUSINESS WIRE)-- Innoviva, Inc. (the "Company" or "Innoviva") (NASDAQ: INVA) is pleased to announce that, based on the advice of its proxy solicitor, the Company believ...
Apr 19, 2017
BRISBANE, Calif.--(BUSINESS WIRE)-- Innoviva, Inc. (the "Company" or "Innoviva") (NASDAQ: INVA) today called upon shareholders to make the clear choice to vote FOR the Company's Board of Directors (the "Board"). TheĀ Annual Meeting of Stockholders is scheduled to be held tomorrow, April 20, 2017, but there is stil...
Apr 18, 2017
Innoviva Board Recommends Shareholders Vote "FOR" All of Innoviva's Qualified Directors on the WHITE Proxy Card Value Creating Strategy Supported by Innoviva's Most Important Partner, GlaxoSmithKline BRISBANE, Calif.--(BUSINESS WIRE)-- Innoviva, Inc. (the "Company" o...
Apr 17, 2017
BRISBANE, Calif.--(BUSINESS WIRE)-- Innoviva, Inc. (the "Company" or "Innoviva") (NASDAQ: INVA) today announced its Board of Directors has issued the following letter to shareholders in connection with the upcoming Annual Meeting of Stockholders to be held on April 20, 2017. This Smart News Release...
Apr 13, 2017
Meaningful reductions in core operating costs expected BRISBANE, Calif.--(BUSINESS WIRE)-- Innoviva, Inc. (the "Company" or "Innoviva") (NASDAQ: INVA) issued the following statement ahead of its upcoming Annual Meeting of Stockholders to be held on April 20, 2017: In...
Apr 10, 2017
Recommends Shareholders Vote FOR ALL Innoviva Nominees on the WHITE Proxy Card BRISBANE, Calif.--(BUSINESS WIRE)-- Innoviva, Inc. (the "Company" or "Innoviva") (NASDAQ:INVA) today commented on reports issued by Institutional Shareholder Services ("ISS") and Glass, Lewis & Co. ("Glas...
Apr 10, 2017
Accelerated Notes Redemption Resulting from the Company's Continuing Growth in Royalty Revenue and Cash Flows BRISBANE, Calif.--(BUSINESS WIRE)-- Innoviva, Inc. (the "Company" or "Innoviva") (Nasdaq: INVA) today announced that on May 15, 2017, the next interest payment date under its ...
FirstPrevious
3
...
NextLast
= add release to Briefcase

Innoviva NASDAQ: INVA

$13.06 0.09 (0.69%) 11/17/17 4:00 PM ET Refresh Quote

Data provided by Nasdaq.
Minimum 15 minutes delayed.

Contact

Innoviva Investor Relations & Media
650.238.9640

For business development inquiries,
please contact bd@inva.com.